Switzerland · Research startup
Switzerland · Vaderis Therapeutics AG
Vaderis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland.
Funding reportedLast round: Series A
About Vaderis Therapeutics AG
Vaderis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland.
The company is dedicated to discovering and advancing treatments for rare vascular diseases, particularly those related to vascular malformations and hereditary hemorrhagic telangiectasia (HHT). Vaderis is focused on developing breakthrough therapies, with its main product candidate being VAD044, also known as engasertib. This oral therapy aims to restore vascular balance through targeted AKT inhibition. The company is actively engaged in clinical development, including a proof-of-concept trial for HHT and a global Phase 3 HEROIC study for engasertib. Vaderis operates as a drug-development biotech firm, conducting research and preparing for the commercialization of therapies aimed at improving the lives of patients with rare vascular diseases.
What company datasets say Vaderis Therapeutics AG raised
Funding, as reported
Founders and team
From Vaderis Therapeutics AG's own website: 9 on the team.
- Francesco DraettaDirector
- Giovanni MariggiChair
- Giuliano MarosticaDirector
- Nick WilliamsDirector
- Vaderis TherapeuticsDirector
- Karen ZylbermanTeam
- Maria BuckleyTeam
- Moon Hui KimTeam
- Tom HarrisTeam
On a portfolio page
Investors who name them
Each firm lists Vaderis Therapeutics AG on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
biotechnology researchservicesb2b
Built with from their website
Google Tag ManagerWordPress.orgApacheElementorViewport MetaHornetsecurity Spam and Malware ProtectionHello ElementorPriority HintsCAPTCHAGoogle Font API
+8 more
imagesLoadedMicrosoft ExchangeSalesforceMySQLPrimeNGMicrosoft 365 Apps & ServicesMobile FriendlyBootstrap
- Sector
- Research
- Industry code
- NAICS 541714, SIC 2834
- Region
- Basel-Stadt
- Full record
- Every detail in the company directory
Research in Switzerland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Vaderis Therapeutics AG in front of investors. Or tell us what we have wrong.